New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Gene changes may predict breast cancer relapse, study suggests

Gene changes may predict breast cancer relapse, study suggests

by University of EdinburghMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainScientists have identified genetic changes that may predict the likeliho
Oncology March 01,2024
Gene changes may predict breast cancer relapse, study suggests

Gene changes may predict breast cancer relapse, study suggests

by University of EdinburghMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainScientists have identified genetic changes that may predict the likeliho
Oncology March 01,2024
Research identifies cells that may be responsible for prostate cancer recurrence

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer
Oncology March 01,2024
Research identifies cells that may be responsible for prostate cancer recurrence

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer
Oncology March 01,2024
Researcher and her students discover lesser-known gene associated with breast cancer

Researcher and her students discover lesser-known gene associated with breast cancer

by Villanova UniversityCredit: Villanova UniversityVillanova University biology professor Janice Knepper, PhD, and her students have discovered that a gene, previously poorly characterized, can b
Oncology March 01,2024
Researcher and her students discover lesser-known gene associated with breast cancer

Researcher and her students discover lesser-known gene associated with breast cancer

by Villanova UniversityCredit: Villanova UniversityVillanova University biology professor Janice Knepper, PhD, and her students have discovered that a gene, previously poorly characterized, can b
Oncology March 01,2024
Study sheds new light on mechanism of breast cancer treatment resistance

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina
Oncology March 01,2024
Study sheds new light on mechanism of breast cancer treatment resistance

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina
Oncology March 01,2024
Novel genomics tool enables more accurate identification of rare mutations in cancer cells

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s
Oncology March 01,2024
Novel genomics tool enables more accurate identification of rare mutations in cancer cells

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s
Oncology March 01,2024
Japan to trial 'world's first urine test' to spot cancer

Japan to trial 'world's first urine test' to spot cancer

Credit: CC0 Public DomainA Japanese firm is poised to carry out what it hailed as the world's first experiment to test for cancer using urine samples, which would greatly facilitate screening for
Oncology March 01,2024
Japan to trial 'world's first urine test' to spot cancer

Japan to trial 'world's first urine test' to spot cancer

Credit: CC0 Public DomainA Japanese firm is poised to carry out what it hailed as the world's first experiment to test for cancer using urine samples, which would greatly facilitate screening for
Oncology March 01,2024
Researchers show aspirin added to cancer drug improves effectiveness

Researchers show aspirin added to cancer drug improves effectiveness

by University of QueenslandCredit: University of QueenslandAdding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment, new r
Oncology March 01,2024
Researchers show aspirin added to cancer drug improves effectiveness

Researchers show aspirin added to cancer drug improves effectiveness

by University of QueenslandCredit: University of QueenslandAdding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment, new r
Oncology March 01,2024
More than half a million breast cancer deaths averted in the US over three decades

More than half a million breast cancer deaths averted in the US over three decades

by WileyMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainLatest U.S. estimates indicate that since 1989, hundreds of thousands of women's lives
Oncology March 01,2024
More than half a million breast cancer deaths averted in the US over three decades

More than half a million breast cancer deaths averted in the US over three decades

by WileyMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainLatest U.S. estimates indicate that since 1989, hundreds of thousands of women's lives
Oncology March 01,2024
Workaround erases side effects of promising cell-based cancer therapy

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret
Oncology March 01,2024
Workaround erases side effects of promising cell-based cancer therapy

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret
Oncology March 01,2024
Researchers identify a process responsible for therapeutic resistance in breast cancer

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is
Oncology March 01,2024
Researchers identify a process responsible for therapeutic resistance in breast cancer

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is
Oncology March 01,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com